跳至主導覽
跳至搜尋
跳過主要內容
長庚大學學術能量集萃 首頁
說明與常見問題
English
中文
首頁
學者概覽
研究單位
研究產出
研究計畫-專案
獎項
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
蕭 永晉
助理教授
,
生物醫學研究所(含碩博士班。碩士班分3組)
https://orcid.org/0000-0003-0046-3016
電子郵件
D000011262
cgu.edu
tw
h-index
h10-index
h5-index
656
引文
16
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
384
引文
11
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
112
引文
5
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2007
2024
每年研究產出
概覽
指紋
網絡
研究計畫-專案
(11)
研究產出
(34)
相近領域學者
(6)
指紋
查看啟用 Yung-Chin Hsiao 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Biochemistry, Genetics and Molecular Biology
Sample
100%
Protein
96%
Mass Spectrometry
51%
Peptide
40%
Snake
34%
Cancer Cell
33%
MMP1
28%
Proteomics
28%
Development
25%
Time
24%
Secretome
24%
Antivenom
20%
Proteome
14%
Phospholipase A2
13%
Antibody
13%
Comprehension
13%
Species
11%
Target Peptide
11%
Chromosome 4 (Human)
11%
Horse
11%
Time-of-Flight Mass Spectrometry
11%
Bone
11%
High Risk Population
11%
Aptamer
11%
Target Cell
11%
Clinical Research
11%
Equus
11%
Antibody Affinity
11%
Rodent
11%
Matrix Metalloproteinase
11%
Naja
11%
Gelsolin
11%
Matrix-Assisted Laser Desorption-Ionization
11%
Light
11%
Case Report
11%
Bungarotoxin
11%
Fluorescence
8%
Monoclonal Antibody
8%
Tandem Mass Spectrometry
8%
Small Molecule
7%
Liquid Chromatography Mass Spectrometry
7%
Survival
6%
Accuracy
6%
Chromosome 4
5%
Blood Level
5%
Pharmacology, Toxicology and Pharmaceutical Science
Venom
43%
Protein
40%
Antivenom
32%
Snakebite
29%
Mouth Cancer
24%
Cytotoxin
24%
Lung Cancer
23%
Flavanone
23%
Enzyme-Linked Immunosorbent Assay
23%
Envenomation
22%
Biological Marker
22%
Naja
21%
Apoptosis
15%
Naja Atra
15%
Peptide
14%
Snake Venom
14%
Monoclonals
12%
Leukemia
11%
Tumor Growth
11%
Proteinase
11%
Tannin
11%
Arsenite
11%
Immunoprecipitation
11%
Horse
11%
Mahonia
11%
Cycline
11%
Metastasis
11%
Equus
11%
Cell Cycle
11%
Cations
11%
Deinagkistrodon acutus
11%
Saliva Protein
11%
Protein
11%
Snake
11%
Diseases
7%
Malignant Neoplasm
7%
Retinoic Acid
6%
Necrosis
5%
Medicine and Dentistry
Malignant Neoplasm
31%
Multiple Reaction Monitoring
27%
Polypeptide
23%
Cancer Prognosis
23%
Cancer Diagnosis
23%
Colorectal Carcinoma
23%
Colorectal Cancer
20%
Protein
17%
Combination Therapy
16%
Assessment
16%
Cancer Cell
15%
Biological Marker
15%
Assay
13%
Rhinoplasty
11%
Implant
11%
Silicone
11%
Politef
11%
Interstitial Collagenase
11%
Diagnosis
11%
Mouth Squamous Cell Carcinoma
11%
Donor
11%
Mass Spectrum
11%
In Vitro
11%
B Raf Kinase
11%
Lung Cancer
11%
Quantitative Analysis
11%
Plasma
11%
Programmed Cell Death
11%
Mutant
11%
Saliva Protein
11%
Bone Marrow Stromal Antigen 2
11%
Chromatography
11%
Disease
9%
Mass Screening
9%
Specimen
9%
Cells
8%
Peptide
8%
Saliva
7%
Patient
7%
Cancer Tissue
6%
Species
5%
